Exact Sciences Corp
NASDAQ:EXAS

Watchlist Manager
Exact Sciences Corp Logo
Exact Sciences Corp
NASDAQ:EXAS
Watchlist
Price: 50.88 USD 0.3% Market Closed
Market Cap: 9.4B USD
Have any thoughts about
Exact Sciences Corp?
Write Note

Exact Sciences Corp
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Exact Sciences Corp
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Exact Sciences Corp
NASDAQ:EXAS
Cash from Financing Activities
$231.4m
CAGR 3-Years
-36%
CAGR 5-Years
-2%
CAGR 10-Years
5%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Exact Sciences Corp's Cash from Financing Activities?
Cash from Financing Activities
231.4m USD

Based on the financial report for Sep 30, 2024, Exact Sciences Corp's Cash from Financing Activities amounts to 231.4m USD.

What is Exact Sciences Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
5%

Over the last year, the Cash from Financing Activities growth was 45%. The average annual Cash from Financing Activities growth rates for Exact Sciences Corp have been -36% over the past three years , -2% over the past five years , and 5% over the past ten years .

Back to Top